Pharmstandard

Russia
Sales: €312.8 million
Profits: €88.8 million

The bulk of Pharmstandard's business is manufacturing and selling generic over-the-counter medicines in Russia. Another 15% of sales last year came from development and manufacturing of medical equipment, as well as supplies (such as sterilizing and distilling machines) and disposable medical products (such as syringes). As the Russian economy has grown over the past three years and consumers' standard of living has improved, demand for medicines and Pharmstandard's other products has jumped.